Buy & Sell Xpeng Inc - ADR (XPEV) – Xpeng Inc - ADR Price Today
Aura AI Summary
Key Stats
- $11.99BMarket Cap
- Consumer CyclicalSector
- -33.17%3M Drawdown
- $14.10BEnterprise Value
- -Dividend Yield
- 66% Buy | 34% SellTrading Activity
- 72 daysTypical Hold Time
Xpeng Inc - ADR (XPEV) is currently valued at a market capitalization of $11.99B, with an enterprise value of $14.10B. Over the past 52 weeks, Xpeng Inc - ADR has traded between a low of $11.73 and a high of $28.07, highlighting its annual price range. Over the past three months, Xpeng Inc - ADR has recorded a drawdown of -33.17%, reflecting recent price volatility. On average, investors hold Xpeng Inc - ADR for approximately 72 days, indicating typical investor behavior on the platform.
About Xpeng Inc - ADR
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Most Recent News
Global cable assembly market to reach $348.66B by 2035, driven by high-speed connectivity and digital infrastructure growth.
The global cable assembly market, valued at $194.54 billion in 2025, is projected to grow to $348.66 billion by 2035 at a CAGR of 6.03%. Growth is fueled by rising demand for high-speed connectivity, 5G networks, cloud computing, and digital infrastr...

Nyrstar shareholders petition court to appoint interim administrator amid ongoing legal disputes.
Certain shareholders of Nyrstar NV have filed a petition with the Antwerp Enterprise Court requesting the appointment of a provisional administrator or an ad hoc trustee to manage the company for at least 12 months. This move is part of ongoing legal...

Bloodstream infection testing market to grow to $1.4B by 2035, driven by rapid diagnostics and sepsis detection demand.
The global bloodstream infection testing market is projected to grow from $876.49 million in 2025 to $1.4 billion by 2035, at a CAGR of 4.8%. Growth is fueled by rising bloodstream infection cases, increased sepsis hospitalizations, and wider adoptio...
